Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Substantia Nigra (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Substantia Nigra (injuries) < Substantia Nigra (metabolism) < Substantia Nigra (pathology)  Facettes :

List of bibliographic references indexed by Substantia Nigra (metabolism)

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]
Ident.Authors (with country if any)Title
000705 (2013) Stefanie Reyes [Australie] ; Veronica Cottam ; Deniz Kirik ; Kay L. Double ; Glenda M. HallidayVariability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
000775 (2013) Chun-Hui Chang [États-Unis] ; Anthony A. GraceSome dopamine neurons may be more impulsive than others: why differences in receptors and transporters can affect dopamine function in Parkinson's disease.
000A84 (2013) Fabiana Novellino [Italie] ; Andrea Cherubini ; Carmelina Chiriaco ; Maurizio Morelli ; Maria Salsone ; Gennarina Arabia ; Aldo QuattroneBrain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study.
000B43 (2013) G. Madeo [Italie] ; T. Schirinzi [Italie] ; G. Martella [Italie] ; E. C. Latagliata [Italie] ; F. Puglisi [Italie] ; J. Shen [États-Unis] ; E. M. Valente [Italie] ; M. Federici [Italie] ; N. B. Mercuri [Italie] ; S. Puglisi-Allegra [Italie] ; P. Bonsi [Italie] ; A. Pisani [Italie]PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity
000E93 (2012) Kathleen M. Shannon [États-Unis] ; Ali Keshavarzian ; Ece Mutlu ; Hemraj B. Dodiya ; Delia Daian ; Jean A. Jaglin ; Jeffrey H. KordowerAlpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
001361 (2011) Stefan T. Schwarz [Royaume-Uni] ; Timothy Rittman [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Paul S. Morgan [Royaume-Uni] ; Nin Bajaj [Royaume-Uni] ; Dorothee P. Auer [Royaume-Uni]T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease
001579 (2011) Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne]Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
002183 (2009) Maria Stamelou [Allemagne] ; Andreas Matusch [Allemagne] ; David Elmenhorst [Allemagne] ; René Hurlemann [Allemagne] ; Karla M. Eggert [Allemagne] ; Karl Zilles [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Günter U. Höglinger [Allemagne] ; Andreas Bauer [Allemagne]Nigrostriatal upregulation of 5‐HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy
002187 (2009) José-Félix Martí-Mass [Espagne] ; Javier Ruiz-Martínez [Espagne] ; Maria J. Bola O [Espagne] ; Irune Ruiz [Espagne] ; Ana Gorostidi [Espagne] ; Fermin Moreno [Espagne] ; Isidre Ferrer [Espagne] ; Adolfo L Pez De Munain [Espagne]Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2
002732 (2008) Gabor G. Kovacs [Autriche] ; Ivan J. Milenkovic [Autriche] ; Matthias Preusser [Autriche] ; Herbert Budka [Autriche]Nigral burden of α‐synuclein correlates with striatal dopamine deficit
002821 (2008) Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
002853 (2008) Karen E. Murphy [Australie] ; Tanya Karaconji [Australie] ; Craig D. Hardman [Australie] ; Glenda M. Halliday [Australie]Excessive dopamine neuron loss in progressive supranuclear palsy
002991 (2008) Marcus M. Unger [Allemagne] ; Jens C. Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Katharina Mankel [Allemagne] ; Daniela Berg [Allemagne] ; Uwe Walter [Allemagne] ; Helmut Hoeffken [Allemagne] ; Geert Mayer [Allemagne] ; Wolfgang H. Oertel [Allemagne]Assessment of idiopathic rapid‐eye‐movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP‐CIT‐SPECT
002A99 (2007) Harold L. Newmark [États-Unis] ; Jonathan Newmark [États-Unis]Vitamin D and Parkinson's disease—A hypothesis
002B54 (2007) Jana Godau [Allemagne] ; Katherine J. Schweitzer [Allemagne] ; Inga Liepelt [Allemagne] ; Christian Gerloff [Allemagne] ; Daniela Berg [Allemagne]Substantia nigra hypoechogenicity: Definition and findings in restless legs syndrome
002B59 (2007) Christopher D. Herzog [États-Unis] ; Biplob Dass [États-Unis] ; James E. Holden [États-Unis] ; James Stansell Iii [États-Unis] ; Mehdi Gasmi [États-Unis] ; Mark H. Tuszynski [États-Unis] ; Raymond T. Bartus [États-Unis] ; Jeffrey H. Kordower [États-Unis]Striatal delivery of CERE‐120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys
002C26 (2007) Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France]Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias
002C91 (2007) Maria Teresa Pellecchia [Italie] ; Andrea Varrone [Italie] ; Grazia Annesi [Italie] ; Marianna Amboni [Italie] ; Giulio Cicarelli [Italie] ; Valeria Sansone [Italie] ; Ferdinanda Annesi [Italie] ; Francesca Emanuela Rocca [Italie] ; Carmine Vitale [Italie] ; Sabina Pappatà [Italie] ; Aldo Quattrone [Italie] ; Paolo Barone [Italie]Parkinsonism and essential tremor in a family with pseudo‐dominant inheritance of PARK2: An FP‐CIT SPECT study
002D21 (2007) Maria Teresa Giordana [Italie] ; Carla D'Agostino [Italie] ; Giovanni Albani [Italie] ; Alessandro Mauro [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Angelo Antonini [Italie] ; Vincenzo Bonifati [Pays-Bas]Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
003317 (2006) Michele T. M. Hu [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Jo V. Hajnal [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; David J. Brooks [Royaume-Uni]Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin‐linked Parkinson's disease
003346 (2006) Uday B. Muthane [Inde] ; Yasha T. Chickabasaviah [Inde] ; Jasmine Henderson [Australie] ; Ann E. Kingsbury [Royaume-Uni] ; Linda Kilford [Royaume-Uni] ; Susarla K. Shankar [Inde] ; D. K. Subbakrishna [Inde] ; Andrew Lees (neurologue) [Royaume-Uni]Melanized nigral neuronal numbers in Nigerian and British individuals

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Substantia Nigra (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Substantia Nigra (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Substantia Nigra (metabolism)
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024